Robotic Radiotherapy Market Report 2025

This Robotic Radiotherapy market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The robotic radiotherapy Market size has grown rapidly in recent years. It will grow from $1.06 billion in 2024 to $1.17 billion in 2025 at a compound annual growth rate (CAGR) of 10.9%. The growth observed during the historical period can be attributed to improvements in the accuracy of robotic systems, the integration of AI in treatment planning, increased accessibility to healthcare, a growing focus on patient-specific treatments, and increased investments in the private healthcare sector.

The robotic radiotherapy market size is expected to see rapid growth in the next few years. It will grow to $1.75 billion in 2029 at a compound annual growth rate (CAGR) of 10.6%. In the forecast period, growth is expected to be driven by factors such as the rising global aging population, advancements in machine learning for treatment planning, a growing preference for outpatient treatments, the expansion of robotic-assisted surgical systems, and increased collaborations between healthcare providers and technology companies. Key trends in the forecast period include advancements in motion management systems, the growth of cloud-based radiotherapy platforms, the integration of wearable technology for patient monitoring, the development of smaller and more efficient robotic systems, and an increase in the use of stereotactic radiosurgery techniques.

The increasing demand for minimally invasive procedures is anticipated to drive the growth of the robotic radiotherapy market. Minimally invasive treatments, which are characterized by smaller incisions, quicker recovery times, and fewer complications, are gaining popularity due to technological advancements, patient preferences, and healthcare providers' desire to improve clinical outcomes while reducing costs. Robotic radiotherapy, which offers highly targeted radiation to tumors, exemplifies the benefits of minimally invasive treatments. By precisely directing radiation doses to cancerous tissues while sparing healthy surrounding areas, robotic radiotherapy minimizes damage, reduces recovery times, and enhances patient outcomes. A report from the American Society of Plastic Surgeons indicated a 7% increase in minimally invasive procedures in 2023 compared to the previous year, underscoring the growing trend and highlighting the potential for robotic radiotherapy to contribute to this market expansion.

Key players in the robotic radiotherapy market are focusing on integrating cutting-edge technologies such as artificial intelligence (AI) to enhance precision and accuracy in cancer treatment. AI-powered robotic systems reduce human error, improve consistency, and accelerate recovery times by utilizing advanced sensors, actuators, and algorithms. For instance, Tampa General Hospital introduced the CyberKnife S7 in January 2024, a state-of-the-art AI-powered radiosurgery tool. This innovative technology enables precise, non-invasive cancer treatments, targeting tumors with minimal damage to surrounding tissues. The CyberKnife S7 is an example of the advanced technologies that are making robotic radiotherapy an increasingly effective and patient-friendly treatment option for both benign and malignant tumors, as well as neurological disorders.

In May 2022, Brainlab AG, a German medical technology company, expanded its radiotherapy capabilities by acquiring MedPhoton GmbH, an Austria-based company specializing in robotic imaging solutions. This acquisition enables Brainlab to integrate MedPhoton’s advanced imaging technology into its portfolio, enhancing the precision and effectiveness of image-guided radiation therapy (IGRT) and navigational surgery. MedPhoton’s solutions contribute to improving the targeting of radiation, minimizing errors in treatment delivery, and enhancing the overall success of robotic radiotherapy. This strategic acquisition underscores the growing emphasis on improving the precision of robotic radiotherapy and highlights the increasing importance of robotic imaging solutions in advancing cancer treatment.

Major players in the robotic radiotherapy market are Panasonic Healthcare, Siemens Healthineers AG, Fujifilm Medical Systems, GE Healthcare Technologies Inc., Varian Medical Systems, Kuka AG, Elekta AB, Accuray Incorporated, Brainlab AG, Mevion Medical Systems Inc., ViewRay Technologies Inc., RaySearch Laboratories AB, VisionRT Ltd., MIM Software Inc., CIVCO Radiotherapy, ProNova Solutions, IntraOp Medical Corporation, IBA Group, Xcision Medical Systems LLC, and C-RAD AB.

North America was the largest region in the robotic radiotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in robotic radiotherapy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the robotic radiotherapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Robotic radiotherapy is an innovative cancer treatment technique that integrates robotic technology with precise radiation delivery to target tumors with sub-millimeter accuracy. It utilizes real-time imaging and motion tracking to adjust to tumor movement, such as that caused by breathing, ensuring minimal harm to surrounding healthy tissues. This method enables non-invasive, highly tailored treatments, enhancing patient outcomes and minimizing side effects.

The primary products in the robotic radiotherapy market include radiotherapy systems, software, and 3D cameras (surface-guided). Radiotherapy systems are advanced medical devices and technologies used to treat cancer and other conditions through radiation. These systems include technologies such as linear accelerators, conventional linear accelerators, MRI-linear accelerators, stereotactic radiation therapy systems, cyberknife, gamma knife, particle therapy, and proton beam therapy. These systems are used for treating various cancers, including prostate, breast, lung, head and neck, and colorectal cancers. The key end users of these products are hospitals and independent radiotherapy centers.

The robotic radiotherapy market research report is one of a series of new reports that provides robotic radiotherapy market statistics, including robotic radiotherapy industry global market size, regional shares, competitors with a robotic radiotherapy market share, detailed robotic radiotherapy market segments, market trends and opportunities, and any further data you may need to thrive in the robotic radiotherapy industry. This robotic radiotherapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The robotic radiotherapy market consists of revenues earned by entities by providing services such as treatment planning services, imaging and diagnostics, robotic system operation, and maintenance. The market value includes the value of related goods sold by the service provider or included within the service offering. The robotic radiotherapy market also includes sales of linear accelerators, radiotherapy accessories, immobilization devices, shielding equipment, and fiducial markers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.